Patient Reported Outcomes Have Arrived: A Practical Overview for Clinicians in Using Patient Reported Outcomes in Oncology

被引:64
|
作者
Warsame, Rahma [1 ]
D'Souza, Anita [2 ]
机构
[1] Mayo Clin, Dept Med, Div Hematol, Rochester, MN USA
[2] Med Coll Wisconsin, Dept Med, Div Hematol Oncol, Milwaukee, WI 53226 USA
关键词
QUALITY-OF-LIFE; DRUG DEVELOPMENT; ADVERSE EVENTS; CANCER; TRIALS; COMMUNICATION; SURVIVAL; THERAPY; TRANSPLANTATION; RELIABILITY;
D O I
10.1016/j.mayocp.2019.04.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ensuring that the patient's voice is routinely incorporated in all aspects of health care in oncology is essential to provide quality care. Patient reported outcomes (PROs) are standardized measures that are used to obtain the patient's perspective and are increasingly used in all aspects of health care to ensure optimal delivery of patient-centered care. The US Food and Drug Administration encourages that PROs be used in studies for label indications. There are no uniform standardized methods to use PROs nor is there consensus on which PROs are best for regulatory approval, comparative effectiveness research, toxicity assessment, health-related quality of life, or symptom monitoring. For this review, we conducted a literature search using PubMed and Google Scholar, and herein summarize the evidence related to the use of PROs in clinic care and research. Using valid, reliable, and easily interpretable PROs developed in comparable populations will provide the most useful results. Various ways that PROs can be used successfully in oncology have been exemplified in this overview to provide clinicians and researchers practical guidance. (C) 2019 Mayo Foundation for Medical Education and Research.
引用
收藏
页码:2291 / 2301
页数:11
相关论文
共 50 条
  • [21] Patient reported outcomes in oncology: changing perspectives—a systematic review
    Augusta Silveira
    Teresa Sequeira
    Joaquim Gonçalves
    Pedro Lopes Ferreira
    Health and Quality of Life Outcomes, 20
  • [22] METHODS FOR ANALYZING PATIENT-REPORTED OUTCOMES IN ONCOLOGY TRIALS
    Williams, P.
    Fofana, F.
    de la Loge, C.
    Arnould, B.
    VALUE IN HEALTH, 2016, 19 (07) : A399 - A399
  • [23] Impacts of routine patient-reported-outcomes monitoring in oncology
    Fiteni, Frederic
    Favier, Mireille
    Bascoul-Mollevi, Caroline
    Gourgou, Sophie
    Cousin, Christelle
    Houede, Nadine
    BULLETIN DU CANCER, 2018, 105 (09) : 847 - 848
  • [24] Patient reported outcomes in psoriasis
    Garcia-Diez, A.
    Ferrandiz, C.
    Bermudez-Rey, L.
    Espallardo, O.
    Lizan, L.
    Badia, X.
    VALUE IN HEALTH, 2007, 10 (06) : A471 - A471
  • [25] PATIENT REPORTED OUTCOMES FOR METOIDIOPLASTY
    Kuehhas, F.
    De Luca, F.
    Spilotros, M.
    Richardson, S.
    Garaffa, G.
    Ralph, D.
    Christopher, N.
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 221 - 221
  • [26] PATIENT-REPORTED OUTCOMES IN LABELING FOR NOVEL ONCOLOGY AGENTS
    Champion, A.
    VALUE IN HEALTH, 2019, 22 : S107 - S107
  • [27] Integration of clinical and patient-reported outcomes in surgical oncology
    Macefield, R. C.
    Avery, K. N. L.
    Blazeby, J. M.
    BRITISH JOURNAL OF SURGERY, 2013, 100 (01) : 28 - 37
  • [28] Role of Patient-Reported Outcomes in Postsurgical Monitoring in Oncology
    Smith, Angela B.
    Basch, Ethan
    JOURNAL OF ONCOLOGY PRACTICE, 2017, 13 (08) : 535 - +
  • [29] TRANSLATING PATIENT-REPORTED OUTCOMES INTO DECISION MAKING IN ONCOLOGY
    Salek, Sam
    Novik, Andrei A.
    Ionova, Tatyana I.
    Novik, Andrei A.
    Ionova, Tatyana I.
    QUALITY OF LIFE RESEARCH, 2010, 19 : 7 - 7
  • [30] THE IMPACT OF TELEMEDICINE ON PATIENT-REPORTED OUTCOMES IN UROLOGIC ONCOLOGY
    Gadzinski, Adam
    Abarro, Isabelle
    Stewart, Blair
    Gore, John
    JOURNAL OF UROLOGY, 2021, 206 : E436 - E436